DHEER HEALTHCARE PRIVATE LIMITED

Lapatinib Ditosylate

14000 INR

Product Details:

X

Price And Quantity

  • 14000 INR
  • 1 Crore Piece

Trade Information

  • Cash Advance (CA), Cash in Advance (CID)
  • 1 Piece Crore Per Week
  • 1 Week
  • Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

Product Description

Lapatinib Ditosylate Tablet

Lapatinib is an anti-cancer drug used as a treatment for solid tumours such as breast and lung cancer. It was approved by the FDA on March 13, 2007, for use in patients with advanced metastatic breast cancer in conjunction with the chemotherapy drug Capecitabine. Lapatinib is human epidermal growth factor receptor type 2 (HER2/ERBB2) and epidermal growth factor receptor (HER1/EGFR/ERBB1) tyrosine kinases inhibitor. It binds to the intracellular phosphorylation domain to prevent receptor autophosphorylation upon ligand binding.

Features:

  • Utmost effectiveness
  • Treats advanced breast cancer
  • Precise composition
  • Accurate level of pH
Enter Buying Requirement Details
Email Id
Mobile number

Other Products in 'Breast Cancer Drugs' category



"Accepting orders in bulk order quantity".
DHEER HEALTHCARE PRIVATE LIMITED All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.